Completed PHASE2 INTERVENTIONAL NCT00400036

Dietary Fish Protein in Subjects With Insulin Resistance

Assessment of Insulin Sensitivity in Insulin-Resistant Subjects Fed Fish Protein

Sponsor: Canadian Institutes of Health Research (CIHR)

Conditions Insulin Resistance Type 2 Diabetes

Updated 5 times since 2017 Last updated: Nov 14, 2006 Started: Feb 29, 2004 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Insulin Resistance and Type 2 Diabetes, this trial is completed. The trial is conducted by Canadian Institutes of Health Research (CIHR) and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Feb 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Institutes of Health Research (CIHR)
Laval University

Data source: Laval University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Québec, Canada